Thirty Years of HIV and AIDS: Future Challenges and Opportunities
Open Access
- 7 June 2011
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 154 (11) , 766-771
Abstract
As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occurred in the understanding, treatment, and prevention of HIV infection and AIDS. As a result of these successes, it is now time to focus on future challenges. Paramount among these is reaching the goal of truly controlling and ultimately ending the HIV and AIDS pandemic. To that end, AIDS researchers and public health personnel worldwide are aggressively pursuing 3 key areas of scientific research. Given the availability of highly effective therapeutic regimens for HIV infection, the first challenge is efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART). Second, scientists are trying to develop a cure for HIV infection, which would alleviate the need for lifelong ART. Finally, preventing new cases of HIV infection, which currently number approximately 2.6 million per year globally, is critical to any attempt to end this pandemic. This article addresses each of these challenges and provides directions for the future.Keywords
This publication has 43 references indexed in Scilit:
- Controlling and Ultimately Ending the HIV/AIDS PandemicJAMA, 2010
- Universal Voluntary Testing and Treatment for Prevention of HIV TransmissionJAMA, 2009
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Biomedical interventions to prevent HIV infection: evidence, challenges, and way forwardThe Lancet, 2008
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008
- Can we reverse the HIV/AIDS pandemic with an expanded response?The Lancet, 2002
- Re-emergence of HIV after stopping therapyNature, 1999
- Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapyNature Medicine, 1999
- KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASESThe Lancet, 1981